Chiropractors in Hanover, NH Accepting Medicare
6 Chiropractors found. Showing 1 - 6
 Hanover Family Chiropractic Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 68 Lyme Rd, Hanover, NH 03755 Phone: 603-643-2200 Fax: 603-643-4931 |
 Dr. Theresa Lochner Mundy, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 45 Lyme Rd, Suite 105a, Hanover, NH 03755 Phone: 603-643-2200 Fax: 603-643-4931 |
 Michael Darcy Mundy, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 45 Lyme Rd, Suite105a, Hanover, NH 03755 Phone: 603-643-2200 |
Tory Opal Paulson, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 68 Lyme Rd, Hanover, NH 03755 Phone: 603-643-2200 |
Gateway Chiropractic Of Hanover, Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 10 Buck Rd, Suite 8, Hanover, NH 03755 Phone: 603-667-0095 |
Paulson Chiropractic Chiropractor Medicare: Medicare Enrolled Practice Location: 68 Lyme Rd, Hanover, NH 03755 Phone: 603-643-2200 |
News Archive
Fitnessedge.net adds new articles on using hGH peptides for anti-aging, hGH replacement therapy
Fitnessedge.net, a website that is devoted to offering readers the most up-to-date information about various weight loss programs, has just added some new and educational articles on using hGH peptides for anti-aging and hGH replacement therapy.
New study reports more practical approach to heal the heart after a heart attack
Stem cell have been the main focus of healing therapy research because they can morph into new cells, and using a patient's own stem cells will not induce an autoimmune response. For healing after a heart attack, the ideal time to administer these therapies is when reopening the clogged blood vessel because the heart is easily accessible. While stem cells show promise for heart attack treatment, the process of harvesting and reintroducing the cells—which can take days or weeks—is too slow for this window.
ViroPharma reports results of trial for Maribavir in bone marrow transplant patients
ViroPharma Incorporated has announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint.
Allos Therapeutics announces results from phase 2 trial of Pralatrexate in peripheral T-cell lymphoma
Allos Therapeutics, Inc. has announced preliminary top line results from PROPEL, the Company's pivotal Phase 2 trial of pralatrexate (PDX) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL), at the 50th Annual Meeting of the American Society of Hematology (abstract 261).
LifeVantage reduces operating costs and continues to expand network marketing business
LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of Protandim® and TrueScience(TM) Anti-Aging Cream, science-based solutions for oxidative stress, announced today that it has implemented reductions in operating costs while continuing to concentrate on the science behind its products and supporting the Company's ongoing expansion in the network marketing distribution channel.
› Verified 5 days ago
Physical Therapists
Optometrists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Audiologists